693 related articles for article (PubMed ID: 25473179)
21. Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat.
Pandya HB; Agravat HH; Patel JS; Sodagar NR
Indian J Med Microbiol; 2014; 32(4):408-13. PubMed ID: 25297026
[TBL] [Abstract][Full Text] [Related]
22. The analysis of virulence factors and antibiotic resistance between Helicobacter pylori strains isolated from gastric antrum and body.
Seo JW; Park JY; Shin TS; Kim JG
BMC Gastroenterol; 2019 Aug; 19(1):140. PubMed ID: 31390989
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic susceptibility of Helicobacter pylori in Iceland.
Gunnarsdottir AI; Gudjonsson H; Hardardottir H; Jonsdottir KD; Bjornsson ES
Infect Dis (Lond); 2017 Sep; 49(9):647-654. PubMed ID: 28440099
[TBL] [Abstract][Full Text] [Related]
24. Heteroresistance of Helicobacter pylori from the same patient prior to antibiotic treatment.
Kao CY; Lee AY; Huang AH; Song PY; Yang YJ; Sheu SM; Chang WL; Sheu BS; Wu JJ
Infect Genet Evol; 2014 Apr; 23():196-202. PubMed ID: 24576534
[TBL] [Abstract][Full Text] [Related]
25. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
[TBL] [Abstract][Full Text] [Related]
26. Primary and Secondary Antibiotic Resistance of Helicobacter pylori in Israeli Children and Adolescents.
Kori M; Yahav J; Berdinstein R; Shmuely H
Isr Med Assoc J; 2017 Dec; 19(12):747-750. PubMed ID: 29235736
[TBL] [Abstract][Full Text] [Related]
27. Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates.
Kouitcheu Mabeku LB; Eyoum Bille B; Tepap Zemnou C; Tali Nguefack LD; Leundji H
BMC Infect Dis; 2019 Oct; 19(1):880. PubMed ID: 31640588
[TBL] [Abstract][Full Text] [Related]
28. Levofloxacin resistance of Helicobacter pylori strains isolated from patients in southern Poland, between 2006-2012.
Karczewska E; Klesiewicz K; Wojtas-Bonior I; Skiba I; Sito E; Czajecki K; Zwolińska-Wcisło M; Budak A
Acta Pol Pharm; 2014; 71(3):477-83. PubMed ID: 25265828
[TBL] [Abstract][Full Text] [Related]
29. Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.
Fiorini G; Vakil N; Zullo A; Saracino IM; Castelli V; Ricci C; Zaccaro C; Gatta L; Vaira D
Clin Gastroenterol Hepatol; 2013 May; 11(5):507-10. PubMed ID: 23267869
[TBL] [Abstract][Full Text] [Related]
30. High incidence of antibiotic resistance amongst isolates of
Garvey E; Rhead J; Suffian S; Whiley D; Mahmood F; Bakshi N; Letley D; White J; Atherton J; Winter JA; Robinson K
J Med Microbiol; 2023 Nov; 72(11):. PubMed ID: 37962209
[No Abstract] [Full Text] [Related]
31. Pretreatment antimicrobial susceptibilities of paired gastric Helicobacter pylori isolates: antrum versus corpus.
Ikezawa K; Kashimura H; Kojima M; Aikawa T; Nakahara A; Mutoh H; Tanaka N
Helicobacter; 1999 Dec; 4(4):218-21. PubMed ID: 10597389
[TBL] [Abstract][Full Text] [Related]
32. Characterization of Helicobacter pylori strainsisolated before and after therapy.
Andrzejewska E; Szkaradkiewicz A; Klincewicz H; Linke K
Med Sci Monit; 2003 Sep; 9(9):CR400-4. PubMed ID: 12960930
[TBL] [Abstract][Full Text] [Related]
33. Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001.
Rimbara E; Noguchi N; Tanabe M; Kawai T; Matsumoto Y; Sasatsu M
Clin Microbiol Infect; 2005 Apr; 11(4):307-11. PubMed ID: 15760428
[TBL] [Abstract][Full Text] [Related]
34. Characterization of clarithromycin heteroresistance among Helicobacter pylori strains isolated from the antrum and corpus of the stomach.
Farzi N; Behzad C; Hasani Z; Alebouyeh M; Zojaji H; Zali MR
Folia Microbiol (Praha); 2019 Mar; 64(2):143-151. PubMed ID: 30097895
[TBL] [Abstract][Full Text] [Related]
35. Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.
Wu IT; Chuah SK; Lee CH; Liang CM; Lu LS; Kuo YH; Yen YH; Hu ML; Chou YP; Yang SC; Kuo CM; Kuo CH; Chien CC; Chiang YS; Chiou SS; Hu TH; Tai WC
World J Gastroenterol; 2015 Oct; 21(37):10669-74. PubMed ID: 26457027
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012.
Lee JW; Kim N; Kim JM; Nam RH; Chang H; Kim JY; Shin CM; Park YS; Lee DH; Jung HC
Helicobacter; 2013 Jun; 18(3):206-14. PubMed ID: 23241101
[TBL] [Abstract][Full Text] [Related]
37. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
[TBL] [Abstract][Full Text] [Related]
38. [Antibiotic resistance of Helicobacter pylori].
Wang F; Shen SR; Zhou JD; Xu CX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):447-50. PubMed ID: 17611323
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori antimicrobial resistance rates in the central region of Portugal.
Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Fernandes A; Calhau C; Sofia C
Clin Microbiol Infect; 2014 Nov; 20(11):1127-33. PubMed ID: 24890952
[TBL] [Abstract][Full Text] [Related]
40. PCR-RFLP and antimicrobial susceptibility profiles of Helicobacter pylori isolated from antrum and corpus of dyspeptic patients in Thailand.
Kulsantiwong P; Chomvarin C; Mairiang P; Sangchan A; Chanlertrith K; Chaicumpar K; Namwat W; Kularbkaew C
Southeast Asian J Trop Med Public Health; 2012 Jul; 43(4):933-42. PubMed ID: 23077816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
